NCT06838507View on ClinicalTrials.gov

Incidence, Characterisation and Outcome-relevance of Perioperative SGLT2 Inhibitor Associated Ketoacidosis

Not yet recruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

SGLT2 InhibitorKetoacidosis, Eugylcemic

Trial Locations (1)

40225

Department of Anaesthesiology, University Hospital Duesseldorf, Düsseldorf

All Listed Sponsors

lead

Heinrich-Heine University, Duesseldorf

OTHER

NCT06838507 - Incidence, Characterisation and Outcome-relevance of Perioperative SGLT2 Inhibitor Associated Ketoacidosis | Biotech Hunter | Biotech Hunter